Id: acc4924
Group: 1sens
Protein: ERK1
Gene Symbol: Mapk3
Protein Id: Q63844
Protein Name: MK03_MOUSE
PTM: phosphorylation
Site: Thr202
Site Sequence: DPEHDHTGFLTEYVATRWYRA
Disease Category: Cancer
Disease: Lung Cancer
Disease Subtype: Pulmonary Carcinomas
Disease Cellline:
Disease Info:
Drug: U0126
Drug Info: "U0126 is a specific drug, but without further context, a detailed description cannot be provided. "
Effect: modulate
Effect Info: "The MEK1/2 inhibitor U0126 or MEK1/2 siRNA can inhibit the phosphorylation of ERK1/2, indicating that the MAPK pathway is effectively blocked, which may then relieve the negative regulation of LXR or IFN-gamma expression."
Note:
Score: 4.0
Pubmed(PMID): 24947959
Sentence Index:
Sentence:

Sequence & Structure:

MAAAAAAPGGGGGEPRGTAGVVPVVPGEVEVVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAPTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFDMELDDLPKERLKELIFQETARFQPGAPEGP

No data.

Known Drugs:

source: Multi-Sources

(see table)

No data.

Protein Tractability:

source: Open Targets

No data.

PTM Intensity:

source: CPTAC

No data.

PTM-Disease Association:

source: PTMD
Residue Position State Disease Class PMID
T 203 U Squamous cell carcinoma Phosphorylation 19934324

State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.

PTM-Drug Perturbation Response:

source: DecryptM

No data.

Function score:

source: funscoR

No data.

Cross Links: